Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 5/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.46 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | F2 | P00734 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17645582 | 0.80 | SLC6A2 (0.41) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL2302238 | 0.78 | DPP4 (0.48) | TAAR1DPP4F2HTR2AADRA2A | |
| SCHEMBL5029899 | 0.78 | RIPK1 (0.43) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL11968994 | 0.77 | TAAR1 (0.44) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL29998636 | 0.77 | TAAR1 (0.45) | TAAR1SLC6A2AOC3RIPK1HTR2A | |
| SCHEMBL3668659 | 0.75 | DPP4 (0.40) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL23880379 | 0.74 | RIPK1 (0.40) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL327102 | 0.74 | RIPK1 (0.40) | TAAR1SLC6A2DPP4F2AOC3 | |
| SCHEMBL10476770 | 0.74 | RIPK1 (0.43) | SLC6A2DPP4AOC3RIPK1SLC6A4 | |
| SCHEMBL3018884 | 0.74 | RIPK1 (0.40) | SLC6A2DPP4F2AOC3RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080281112-A1 | Diamine and polyamic acid derived therefrom for liquid crystal orientation applications | DAILY POLYMER CO., LTD. | 2008-11-13 | — | — | US | claimed |
| US-20080058496-A1 | Polyamic acid-based composition, and liquid crystal orienting agent and orienting film containing the same | DAILY POLYMER CO., LTD. | 2008-03-06 | — | — | US | claimed |
| CN-101085867-A | Polyamic acid composition, and liquid crystal alignment agent and alignment film using same | DAILY POLYMER CORP (CN) | 2007-12-12 | — | — | CN | claimed |
| EP-0607976-B1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL IND LTD (JP) | 2002-11-13 | — | — | EP | claimed |
| US-6441127-B1 | COMPRISING A POLYIMIDE FOR A SUPER-TWISTED NEMATIC LIQUID CRYSTAL CELL, DERIVED FROM UNITS OF AROMATIC DIAMINES AND SPECIFIED TETRACARBOXYLIC ACIDS SUCH AS PYROMELLITIC ACID | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2002-08-27 | — | — | US | claimed |
| US-6139917-A | Liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-31 | — | — | US | claimed |
| EP-0564009-B1 | Electric and electronic devices having a polyimide resin insulating film | NISSAN CHEMICAL IND LTD (JP) | 1997-09-17 | — | — | EP | claimed |
| EP-0540829-B1 | Novel liquid crystal alignment treating agent | NISSAN CHEMICAL IND LTD (JP) | 1997-02-26 | — | — | EP | claimed |
| EP-0527439-B1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL IND LTD (JP) | 1996-05-29 | — | — | EP | claimed |
| US-5350539-A | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-09-27 | — | — | US | claimed |
| EP-0607976-A1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-07-27 | — | — | EP | claimed |
| US-5298590-A | Polyamide resin consisting diamine including aromatic diamine having at least one linear alkyl group | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1994-03-29 | — | — | US | claimed |
| EP-0564009-A1 | Electric and electronic devices having a polyimide resin insulating film | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-10-06 | — | — | EP | claimed |
| EP-0540829-A1 | Novel liquid crystal alignment treating agent | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-05-12 | — | — | EP | claimed |
| EP-0527439-A1 | Alignment treating agent for liquid crystal cell | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1993-02-17 | — | — | EP | claimed |
| US-5070182-A | CYCLOBUTANETETRACARBOXYLIC ACID MONOMER | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1991-12-03 | — | — | US | claimed |
| EP-0249881-B1 | LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1990-10-03 | — | — | EP | claimed |
| US-RE33342-E | Liquid crystal aligning agent from tetracarboxylic acid dianhydride, diamine and monoamine | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1990-09-18 | — | — | US | claimed |
| US-4749777-A | POLYIMIDE FILMS | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1988-06-07 | — | — | US | claimed |
| EP-0249881-A1 | Liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1987-12-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080281112-A1 | Diamine and polyamic acid derived therefrom for liquid crystal orientation applications | DAO, F12, PARG | TAAR1 1446/4885SLC6A2 3753/4885DPP4 2258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.